Location: Home
  • search
  • go
  • Relate News
  • 11/1/2021HUTCHMED and AZ Initiate SAMETA Global P3 Trial of Savolitinib in Com...
  • 11/1/2021LianBio Raises $325 Million in IPO
  • 11/1/2021Shanghai's Low-Cost Supplementary Health Insurance Huhuibao Enrollment...
  • 11/1/2021Antengene Receives U.S. IND Approval for Phase 1 Trial of ATG-101 in S...
  • 10/30/2021Financial-related Company News in Brief
  • 10/30/2021Recent Executive Moves
  • 10/29/2021NMPA Announces Package Insert Revision of Zoledronic Acid Injection
  • 10/29/2021Pfizer Drones Light Up Night Sky in China's Remote Area with Health Ti...
  • 10/29/2021Seagen Stands by Newly Acquired HER2 Breast Cancer Drug Despite Compet...
  • 10/28/2021Updated Toby's Unofficial Chinese Orange Book User Guide
  • 10/28/2021NHC Releases the Draft Rules for Internet Diagnosis and Treatment Regu...
  • 10/28/2021KoBioLabs Announces Licensing Deal with SPH SINE for KBL697 and KBL693...
  • 10/28/2021Novo Nordisk's Xultophy Insulin (degludec/liraglutide) Wins Chinese Ap...
  • 10/28/2021HUYABIO Cleared P1 Trial of SHP2 Inhibitor for KRAS and EGFR Mutated T...
  • 10/27/2021Boehringer Ingelheim Submits Chinese NDA for First-in-class Spesolimab...
  • 10/27/2021Fosun to Take on Pfizer's Prevnar with Acquisition of Antejin Biotech
  • 10/27/2021Jemincare Group Accuses China Bohai Bank of Misusing Its CNY 2.8B Depo...
  • 10/26/2021PhIIC's China Generic Drug Bluebook 2021: Up 3.9% in 2019 but Down 16....
  • 10/26/2021Angel Pharma Announces Chinese IND Approval for ITK Inhibitor CPI-818
  • 10/26/2021I-Mab Enters Strategic Partnership with Sinopharm for Launch of its I...
  • 10/26/2021WHO Clears Chinese HPV Vaccine in Global Battle against Cervical Cance...
  • 10/26/2021SciNeuro and Mabylon to Co-develop Novel Therapeutics for Neurological...
  • 10/26/2021Merck unveils first innovation collaboration site open to startups
  • 10/26/2021How China Turned the Tables on Biopharma's Global Dealmaking: Endpoint
  • 10/26/2021Angel Pharma Announces Chinese IND Approval for ITK Inhibitor CPI-818
  • 10/25/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (51...
  • 10/25/2021111, Inc. and Chugai Pharma Enter Strategic Partnership With to Acce...
  • 10/25/2021CANbridge Enters Global Licensing Pact with Scriptr Global to Develop...
  • 10/25/2021Novartis's NDA for Ribociclib Accepted in China
  • 10/25/2021IQVIA Unveils Comprehensive Analysis of Chinese Retail Pharmacy Market
  • Page:179/789 Total number of articles:23668: [First][<<] [177] [178] [179] [180] [181] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group